Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife Issues

ONCOLife Articles

Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment

30 July 2025

Researchers have enhanced cisplatin’s efficacy in advanced NSCLC by transplanting functional mitochondria from cardiomyocytes into tumors. This combination halved cisplatin’s IC50, boosted T and NK cell infiltration, and reversed the Warburg effect....

From Code to Cure: AI-Designed Proteins Arm T Cells to Precisely Target Cancer

AI | 28 July 2025

Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers

ONCOLife | 24 July 2025

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

ONCOLife | 25 July 2025

START and Advarra Unite to Streamline Early-Phase Oncology Trials with Speed

Digital Health | 25 July 2025

Shane Jacobson Appointed CEO of the American Cancer Society

ONCOLife | 23 July 2025

Leadership Change at V Foundation, Clark Kinlin Appointed Interim CEO

ONCOLife | 22 July 2025

Overcoming Challenges and Expanding Access to CAR T-Cell Therapy

ONCOLife | 2 July 2025

A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy

ONCOLife | 27 June 2025

START Hope Hub Connect Patients and Physicians with Faster, Smarter Trial Access

Digital Health | 18 June 2025

Darolutamide Shows Significant Quality-of-Life Improvements in mCS Prostate Cancer

ONCOLife | 4 June 2025

ATOMIC Trial: Atezolizumab Combo Halves Recurrence in Stage III dMMR Colon Cancer

Targeted ADC ZL-1310 Shows Promising 67% ORR in Heavily Pretreated ES-SC Lung Cancer

ONCOLife

5 June 2025

Darzalex Faspro Achieves Outstanding Results in Multiple Myeloma with 95% 4-Year PFS

ONCOLife

5 June 2025

AMPLITUDE: Niraparib Combo Improves rPFS in HRR-Altered mCS Prostate Cancer

ONCOLife

4 June 2025

Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors

Pharma

4 June 2025

IMforte Study: Tecentriq Plus Lurbinectedin Extends Survival in ES-SC Lung Cancer

ONCOLife

4 June 2025

Enhertu-pertuzumab Combo Shows 44% Risk Reduction in HER2+ Breast Cancer

ONCOLife

3 June 2025

FDA Approves Darolutamide Plus ADT for mCS Prostate Cancer

FDA & EMA

3 June 2025

OASIS-4 Trial: Elinzanetant Reduces Hot Flashes in Breast Cancer Treatment

ONCOLife

2 June 2025

Pasritamig’s Favorable Safety and Efficacy in Advanced Prostate Cancer

ONCOLife

1 June 2025

Imdelltra Extends Survival in Small Cell Lung Cancer, Cutting Death Risk by 40%

ONCOLife

2 June 2025

ctDNA-Guided Camizestrant Switch Redefines 1st-Line Breast Cancer Treatment

ONCOLife

1 June 2025

World-First Clinical Trial Confirms Exercise Boosts Survival in Colon Cancer

ONCOLife

1 June 2025

Libtayo Demonstrates 68% Risk Reduction in High-Risk CS Cell Carcinoma

ONCOLife

31 May 2025


About Image

About ONCOLife

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.